Search Results
Efficacy of Niraparib on PFS in Patients With Recurrent Ovarian Cancer
Results from the ENGOT-OV16/NOVA trial: efficacy and safety of niraparib in ovarian cancer
Dr. Mirza on Niraparib Efficacy Across Ovarian Cancer Subgroups
Niraparib Maintenance Therapy in Ovarian Cancer
Jonathan A Ledermann – Maintenance Treatment for Recurrent Ovarian Carcinoma
Ovarian Cancer: Optimizing Treatment With Niraparib
Long-term safety of niraparib maintenance treatment in patients with recurrent ovarian cancer
Case 1: Use of Niraparib in Ovarian Cancer
New PARP Inhibitor Drug Approved to Treat Women with Recurrent Ovarian Cancer
Treating Ovarian Cancer With Niraparib: The NOVA Trial
Niraparib significantly improves outcomes for ovarian cancer patients
Data Demonstrate Efficacy of 3 PARP Inhibitors in Ovarian Cancer
